Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Non-ischemic Preservation of the Donor Heart in Heart Transplantation

NCT: NCT03991923 · ACTIVE_NOT_RECRUITING

NCT IDNCT03991923
StatusACTIVE_NOT_RECRUITING
Start Date2020-11-25
Completion2028-12-31

Brief Summary

The study intends to compare standard ischemic cold static storage (ICSS) of retrieved hearts intended to be transplanted, to non-ischemic heart preservation (NIHP) in a randomized clinical multicentre trial. The primary hypothesis is that the non-ischemic hypothermic cardioplegic preservation (NIHP) is safe and superior to ischemic cold static storage (ICSS) of donor hearts. The study will investigate the safety and superiority of the new methodology in terms of improved immediate and prolonged organ function in adult heart transplanted patients.

Frequently Asked Questions

What is Non-ischemic Preservation of the Donor Heart in Heart Transplantation?

Non-ischemic Preservation of the Donor Heart in Heart Transplantation is a clinical trial registered under NCT03991923. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03991923?

The current status of NCT03991923 (Non-ischemic Preservation of the Donor Heart in Heart Transplantation) is: ACTIVE_NOT_RECRUITING.

When did Non-ischemic Preservation of the Donor Heart in Heart Transplantation start?

Non-ischemic Preservation of the Donor Heart in Heart Transplantation started on 2020-11-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.